25 related articles for article (PubMed ID: 38608838)
1. Anti-Respiratory Syncytial Virus Mechanism of
Du H; Ding J; Wang P; Zhang G; Wang D; Ma Q; Li N; Sun T
Comb Chem High Throughput Screen; 2021; 24(8):1137-1150. PubMed ID: 32957876
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor.
Coates M; Brookes D; Kim YI; Allen H; Fordyce EAF; Meals EA; Colley T; Ciana CL; Parra GF; Sherbukhin V; Stockwell JA; Thomas JC; Hunt SF; Anderson-Dring L; Onions ST; Cass L; Murray PJ; Ito K; Strong P; DeVincenzo JP; Rapeport G
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652242
[TBL] [Abstract][Full Text] [Related]
3. Respiratory Syncytial Virus (RSV) Pulmonary Infection in Humanized Mice Induces Human Anti-RSV Immune Responses and Pathology.
Sharma A; Wu W; Sung B; Huang J; Tsao T; Li X; Gomi R; Tsuji M; Worgall S
J Virol; 2016 May; 90(10):5068-5074. PubMed ID: 26962219
[TBL] [Abstract][Full Text] [Related]
4. Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.
Jacque E; Chottin C; Laubreton D; Nogre M; Ferret C; de Marcos S; Baptista L; Drajac C; Mondon P; De Romeuf C; Rameix-Welti MA; Eléouët JF; Chtourou S; Riffault S; Perret G; Descamps D
Front Immunol; 2021; 12():683902. PubMed ID: 34163482
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effects of curcumin-loaded niosomes on respiratory syncytial virus infection in a mice model.
Samadizadeh S; Arabi MS; Yasaghi M; Salimi V; Tabarraei A; Moradi A; Tahamtan A
J Med Microbiol; 2022 Apr; 71(4):. PubMed ID: 35417322
[TBL] [Abstract][Full Text] [Related]
6. Inhalation of 2, 4-di-tert-butylphenol-Loaded micelles suppresses respiratory syncytial virus infection in mice.
Guo M; Peng J; Guo P; Wang Q; Zhang L; Shen H; Chen F; Zhang P; Lin S; Gao H; Peng H; Mou R; Huang J; Wang J; Luo YS; Zhang K
Antiviral Res; 2024 Jun; 226():105880. PubMed ID: 38608838
[TBL] [Abstract][Full Text] [Related]
7. The immunogenicity and safety of respiratory syncytial virus vaccines in development: A systematic review.
Shan J; Britton PN; King CL; Booy R
Influenza Other Respir Viruses; 2021 Jul; 15(4):539-551. PubMed ID: 33764693
[TBL] [Abstract][Full Text] [Related]
8. Molecular and Cellular Mechanisms of Respiratory Syncytial Viral Infection: Using Murine Models to Understand Human Pathology.
Shilovskiy IP; Yumashev KV; Nikolsky AA; Vishnyakova LI; Khaitov MR
Biochemistry (Mosc); 2021 Mar; 86(3):290-306. PubMed ID: 33838630
[TBL] [Abstract][Full Text] [Related]
9. Respiratory syncytial virus infection in adults.
Falsey AR
Semin Respir Crit Care Med; 2007 Apr; 28(2):171-81. PubMed ID: 17458771
[TBL] [Abstract][Full Text] [Related]
10. Host Components Contributing to Respiratory Syncytial Virus Pathogenesis.
Carvajal JJ; Avellaneda AM; Salazar-Ardiles C; Maya JE; Kalergis AM; Lay MK
Front Immunol; 2019; 10():2152. PubMed ID: 31572372
[TBL] [Abstract][Full Text] [Related]
11. Natural Sources and Bioactivities of 2,4-Di-Tert-Butylphenol and Its Analogs.
Zhao F; Wang P; Lucardi RD; Su Z; Li S
Toxins (Basel); 2020 Jan; 12(1):. PubMed ID: 31935944
[TBL] [Abstract][Full Text] [Related]
12. Challenges in Maximizing Impacts of Preventive Strategies against Respiratory Syncytial Virus (RSV) Disease in Young Children.
Zheng Z
Yale J Biol Med; 2022 Jun; 95(2):293-300. PubMed ID: 35782467
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
